Page last updated: 2024-08-18

arginine vasopressin and Shock, Septic

arginine vasopressin has been researched along with Shock, Septic in 92 studies

Research

Studies (92)

TimeframeStudies, this research(%)All Research%
pre-19905 (5.43)18.7374
1990's5 (5.43)18.2507
2000's43 (46.74)29.6817
2010's36 (39.13)24.3611
2020's3 (3.26)2.80

Authors

AuthorsStudies
Duan, C; He, J; Kuang, L; Li, B; Li, T; Liu, L; Peng, X; Wu, Y; Yang, G; Zhang, J; Zhang, Z; Zhao, H; Zheng, D; Zhu, Y1
Jeon, K; Lee, J; Park, HK; Song, JU; Suh, GY1
Ammar, MA; Der-Nigoghossian, C; Hammond, DA1
Bauer, SR; Duggal, A; Lam, SW; Reddy, AJ; Sacha, GL1
Li, D; Wang, C; Yang, X; Zhang, Z; Zhou, Q1
Anger, KE; DeGrado, JR; Reardon, DP; Szumita, PM1
Lone, NA; Oba, Y1
Bakker, J; Wagener, G1
Chen, XM; Li, T; Liu, L; Xiao, X; Yue, W; Zhen, D; Zhu, Y1
Bissell, BD; Erdman, MJ; Ferreira, JA; Kraemer, DF; Smotherman, C1
He, X; Kjølbye, AL; Laporte, R; Moussa, MD; Reinheimer, TM; Su, F; Taccone, FS; Vincent, JL; Xie, K; Zhang, J1
Carr, AC; Fowler, AA; Natarajan, R; Shaw, GM1
Asfar, P; Radermacher, P; Russell, JA; Tuckermann, J1
Angelini, GD; Belletti, A; Benedetto, U; Biondi-Zoccai, G; Landoni, G; Leggieri, C; Silvani, P; Zangrillo, A1
Russell, JA3
Ertmer, C; Westphal, M1
Holmes, CL; Walley, KR1
Singer, M1
Bauer, SR; Cha, SS; Lam, SW; Oyen, LJ2
Branco, LG; Oliveira-Pelegrin, GR; Ravanelli, MI; Rocha, MJ1
Dörler, J; Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Morgenthaler, NG; Ulmer, H; Wenzel, V1
Maybauer, DM; Maybauer, MO; Traber, DL1
Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Torgersen, C; Wenzel, V1
Ertmer, C; Köhler, G; Lange, M; Moll, K; Morelli, A; Rehberg, S; Schlack, K; Spiegel, HU; Su, F; Van Aken, H; Vincent, JL; Westphal, M1
Meyer, S1
Asfar, P; Calzia, E; Georgieff, M; Giudici, R; Gröger, M; Hauser, B; Laporte, R; Möller, P; Ploner, F; Radermacher, P; Scheuerle, A; Simon, F; Vogt, JA; Wachter, U1
Enkhbaatar, P; Rehberg, S; Traber, DL1
Annane, D; Barrett, L; Blanchard, A; Brouland, JP; de la Grandmaison, GL; Gray, F; Guidoux, C; Mattot, V; Polito, A; Sharshar, T; Siami, S; Singer, M; Sonneville, R; Viltart, O1
Maybauer, MO; Walley, KR1
Annane, D; Bailly-Salin, J; Blanchard, A; Boucly, C; Carlier, R; Haymann, JP; Laborde, K; Maxime, V; Polito, A; Porcher, R; Sharshar, T; Siami, S1
Erren, M; Ertmer, C; Köhler, G; Lange, M; Morelli, A; Rehberg, S; Seisel, J; Spiegel, HU; Su, F; Traber, DL; Van Aken, H; Vincent, JL; Westphal, M1
Adrario, E; Donati, A; Pelaia, P; Preiser, JC1
Christ-Crain, M; Katan, M1
Bauer, SR; Lam, SW1
Ertmer, C; Lange, M; Morelli, A; Rehberg, S; Schneider, M; Traber, DL; Van Aken, H; Vincent, JL; Westphal, M1
Kampmeier, TG; Lange, M; Rehberg, S; Westphal, M1
Dünser, M; Ertmer, C; Kampmeier, TG; Lange, M; Lipke, E; Morelli, A; Rehberg, S; Strohhäcker, AK; Traber, DL; Van Aken, H; Westphal, M; Whorton, E1
Landry, DW; Oliver, JA1
Dünser, MW1
Gortner, L; Gottschling, S; McGuire, W; Meyer, S; Mohammed Shamdeen, G1
Maybauer, DM; Maybauer, MO1
Dünser, MW; Jochberger, S1
Ji, MH; Peng, YG; Wang, X; Yang, JJ1
Lauzier, F; Lesur, O1
Dünser, MW; Luckner, G; Rex, C; Schmittinger, CA; Schröder, DC; Torgersen, C; Ulmer, H1
Botticelli, L; D'Egidio, A; Di Russo, A; Donati, A; Ertmer, C; Kampmeier, T; Landoni, G; Lombrano, MR; Morelli, A; Orecchioni, A; Pietropaoli, P; Rehberg, S; Valentini, A; Westphal, M; Zangrillo, A1
Dong, L; Fan, Y; Ji, M; Li, GM; Li, R; Peng, YG; Wu, J; Yang, J1
Annane, D; Barrett, L; Brouland, JP; Chrétien, F; Gray, F; Guidoux, C; Lorin de la Grandmaison, G; Mattot, V; Polito, A; Sharshar, T; Siami, S; Singer, M; Sonneville, R; Viltart, O1
Cha, SS; Oyen, LJ; Personett, HA; Stollings, JL1
Enkhbaatar, P; Ferdyan, N; La, E; Laporte, R; Qi, S; Rehberg, J; Rehberg, S; Rivière, PJ; Schteingart, CD; Traber, DL; Traber, LD; Wisniewski, K1
Chen, P1
Guzman, JA; Kruse, JA; Rosado, AE1
SHUBIN, H; SUDRANN, RB; WEIL, MH1
ALTURA, BM; HERSHEY, SG; HSU, R; MAZZIA, VD1
Antunes-Rodrigues, J; Branco, LG; Carnio, EC; de Castro, M; Giusti-Paiva, A1
Bredle, DL; Klinzing, S; Meier-Hellmann, A; Reinhart, K; Simon, M1
Bone, HG; Freise, H; Kehrel, BE; Sielenkämper, AW; Van Aken, H; Westphal, M1
Bone, HG; Westphal, M1
Dünser, MW; Hasibeder, WR; Mayr, AJ; Wenzel, V2
Schrier, RW; Wang, W1
Albert, M; Faivre, V; Hayon, D; Losser, MR; Payen, D1
Holmes, CL1
Arendshorst, WJ; Boffa, JJ1
Duenser, MW; Hasibeder, WR1
Antunes-Rodrigues, J; Batalhão, ME; Branco, LG; Carnio, EC; Magder, S; Silva, JS; Stabile, AM1
Schulze, D1
Dünser, MW; Friesenecker, B; Hasibeder, W; Jochberger, S; Knotzer, H; Luckner, G; Mayr, AJ; Mayr, VD; Pajk, W; Schmid, S; Ulmer, H; Wenzel, V1
Asfar, P; Hauser, B; Radermacher, P1
Brandner, J; Dünser, MW; Friesenecker, B; Hasibeder, WR; Hausdorfer, H; Iannetti, C; Knotzer, H; Maier, S; Pajk, W; Torgersen, C; Ulmer, H1
Baghai, A; Gortner, L; Gottschling, S; Meyer, S; Wurm, D1
Dünser, MW; Friesenecker, BE; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Morgenthaler, NG; Wenzel, V1
Dünser, MW; Lindner, KH; Wenzel, V1
Peters, J; Treschan, TA1
Antunes-Rodrigues, J; Carnio, EC; Moreto, V; Stabile, AM1
Lee, CS1
Dünser, MW; Hasibeder, WR; Meier-Hellmann, A; Wenzel, V1
Bergmann, A; Christ-Crain, M; Morgenthaler, NG; Müller, B; Redl, H; Struck, J1
Ertmer, C; Lange, M; Westphal, M1
Inui, D; Nishimura, M; Ohto, J1
Faivre, V; Kopel, T; Losser, MR; Payen, D1
Aiura, K; Endo, M; Kitajima, M; Ueda, M1
Baker, CH; Price, JM; Sutton, ET; Zhou, Z1
Matsuoka, T; Wisner, DH1
Banba, N; Emoto, T; Hattori, Y; Kasai, K; Nakamura, T; Sekiguchi, Y; Shimoda, S; Takahashi, K1
Baker, CH; Dietz, JR; Sutton, ET; Zhou, Z1
Ashton, D; Dytko, G; Huffman, W; Kinter, LB; McDonald, J; Stassen, F1
Baver-Neff, BS; Cronenwett, JL; Grekin, RJ; Sheagren, JN1
Brunner, HR; Nussberger, J; Schaller, MD; Waeber, B1

Reviews

20 review(s) available for arginine vasopressin and Shock, Septic

ArticleYear
Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis.
    Journal of Korean medical science, 2020, Jan-06, Volume: 35, Issue:1

    Topics: Arginine Vasopressin; Humans; Hypotension; Incidence; Medication Adherence; Norepinephrine; Odds Ratio; Shock, Septic; Vasoconstrictor Agents

2020
Narrative Review of Controversies Involving Vasopressin Use in Septic Shock and Practical Considerations.
    The Annals of pharmacotherapy, 2020, Volume: 54, Issue:7

    Topics: Arginine Vasopressin; Arterial Pressure; Body Weight; Humans; Hypotension; Norepinephrine; Practice Guidelines as Topic; Shock, Septic; Vasoconstrictor Agents

2020
Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Journal of critical care, 2014, Volume: 29, Issue:5

    Topics: Arginine Vasopressin; Bayes Theorem; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Norepinephrine; Randomized Controlled Trials as Topic; Shock, Septic; Vasoconstrictor Agents; Vasopressins

2014
Vasopressin in cirrhosis and sepsis: physiology and clinical implications.
    Minerva anestesiologica, 2015, Volume: 81, Issue:12

    Topics: Arginine Vasopressin; Humans; Liver Circulation; Liver Cirrhosis; Sepsis; Shock, Septic; Vasoconstrictor Agents; Vasopressins

2015
The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
    Journal of critical care, 2017, Volume: 37

    Topics: Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Hydrazones; Network Meta-Analysis; Norepinephrine; Odds Ratio; Pyridazines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan; Treatment Outcome; Vasoconstrictor Agents; Vasopressins

2017
Arginine vasopressin in the treatment of vasodilatory septic shock.
    Best practice & research. Clinical anaesthesiology, 2008, Volume: 22, Issue:2

    Topics: Animals; Arginine Vasopressin; Clinical Trials as Topic; Humans; Shock, Septic; Vasoconstrictor Agents; Vasodilation; Vasopressins

2008
Arginine vasopressin vs. terlipressin in the treatment of shock states.
    Best practice & research. Clinical anaesthesiology, 2008, Volume: 22, Issue:2

    Topics: Animals; Arginine Vasopressin; Humans; Infusions, Intravenous; Injections, Intravenous; Lypressin; Shock; Shock, Septic; Terlipressin; Vasoconstrictor Agents

2008
Best vasopressor for advanced vasodilatory shock: should vasopressin be part of the mix?
    Intensive care medicine, 2010, Volume: 36, Issue:9

    Topics: Arginine Vasopressin; Clinical Trials as Topic; Critical Care; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Epinephrine; Humans; Norepinephrine; Resuscitation; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents

2010
The stress hormone copeptin: a new prognostic biomarker in acute illness.
    Swiss medical weekly, 2010, Volume: 140

    Topics: Acute Disease; Adrenocorticotropic Hormone; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Cerebral Infarction; Corticotropin-Releasing Hormone; Glycopeptides; Heart Failure; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Myocardial Infarction; Pituitary-Adrenal System; Pneumonia, Bacterial; Prognosis; Pulmonary Disease, Chronic Obstructive; Sepsis; Shock, Septic; Survival Analysis

2010
Arginine vasopressin for the treatment of septic shock in adults.
    Pharmacotherapy, 2010, Volume: 30, Issue:10

    Topics: Adrenal Cortex Hormones; Adult; Arginine Vasopressin; Drug Dosage Calculations; Drug Interactions; Hemostatics; Humans; Norepinephrine; Randomized Controlled Trials as Topic; Shock, Septic; Time Factors; Vasoconstrictor Agents

2010
Vasopressin in sepsis and septic shock.
    Minerva anestesiologica, 2010, Volume: 76, Issue:10

    Topics: Adrenal Cortex Hormones; Animals; Arginine Vasopressin; Catecholamines; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Humans; Hypotension; Ischemia; Lypressin; Molecular Structure; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Sepsis; Shock, Septic; Terlipressin; Vasoconstriction; Vasoconstrictor Agents

2010
Increased complexity of vasopressin's vascular actions.
    Critical care (London, England), 2010, Volume: 14, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Disease Models, Animal; Female; Receptors, Vasopressin; Shock, Septic

2010
The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.
    Wiener medizinische Wochenschrift (1946), 2011, Volume: 161, Issue:7-8

    Topics: Adolescent; Arginine Vasopressin; Cardiac Output, Low; Cardiopulmonary Resuscitation; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Heart Arrest; Hemodynamics; Hospital Mortality; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lypressin; Male; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Shock, Septic; Survival Rate; Terlipressin; Young Adult

2011
Vasopressin: new uses in critical care.
    The American journal of the medical sciences, 2002, Volume: 324, Issue:3

    Topics: Arginine Vasopressin; Guidelines as Topic; Humans; Hypotension; Models, Chemical; Shock, Septic; Tachycardia, Ventricular; Vasoconstrictor Agents; Ventricular Fibrillation

2002
Acute renal failure and sepsis.
    The New England journal of medicine, 2004, Jul-08, Volume: 351, Issue:2

    Topics: Acute Kidney Injury; Arginine Vasopressin; Hemodynamics; Humans; Nitric Oxide; Sepsis; Shock, Septic; Vasoconstriction; Vasoconstrictor Agents; Vasodilation

2004
Arginine vasopressin in 316 patients with advanced vasodilatory shock.
    Critical care medicine, 2005, Volume: 33, Issue:11

    Topics: Arginine Vasopressin; Blood Pressure; Heart Rate; Humans; Liver; Shock, Septic

2005
The vasopressin system: physiology and clinical strategies.
    Anesthesiology, 2006, Volume: 105, Issue:3

    Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Cardiopulmonary Resuscitation; Hemostasis; Humans; Hypertension; Hypertension, Portal; Neuroendocrine Tumors; Shock, Septic; Vasopressins; Water-Electrolyte Balance

2006
Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
    Critical care nurse, 2006, Volume: 26, Issue:6

    Topics: Arginine Vasopressin; Blood Pressure; Cardiac Output; Catecholamines; Clinical Trials as Topic; Critical Care; Drug Monitoring; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Practice Guidelines as Topic; Research Design; Shock, Septic; Staphylococcal Infections; Treatment Outcome; Vasoconstrictor Agents

2006
[Arginine-vasopressin in septic and vasodilatorial shock].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2006, Volume: 41, Issue:11

    Topics: Arginine Vasopressin; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents

2006
Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
    Intensive care medicine, 2008, Volume: 34, Issue:5

    Topics: Arginine Vasopressin; Humans; Infusions, Intravenous; Lypressin; Metabolic Clearance Rate; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents

2008

Trials

3 trial(s) available for arginine vasopressin and Shock, Septic

ArticleYear
Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study.
    Critical care (London, England), 2010, Volume: 14, Issue:6

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Disease Models, Animal; Female; Receptors, Vasopressin; Sheep; Shock, Septic

2010
Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.
    Critical care (London, England), 2011, Volume: 15, Issue:5

    Topics: Adrenergic alpha-Agonists; Aged; Arginine Vasopressin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lypressin; Male; Microcirculation; Middle Aged; Mouth Floor; Norepinephrine; Prospective Studies; Receptors, Vasopressin; Shock, Septic; Terlipressin

2011
High-dose vasopressin is not superior to norepinephrine in septic shock.
    Critical care medicine, 2003, Volume: 31, Issue:11

    Topics: Adult; Aged; APACHE; Arginine Vasopressin; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Liver Circulation; Male; Middle Aged; Norepinephrine; Renal Agents; Shock, Septic; Vasoconstrictor Agents

2003

Other Studies

69 other study(ies) available for arginine vasopressin and Shock, Septic

ArticleYear
Role of Tumor Necrosis Factor-α in vascular hyporeactivity following endotoxic shock and its mechanism.
    The journal of trauma and acute care surgery, 2019, Volume: 87, Issue:6

    Topics: Animals; Arginine Vasopressin; Calcium; Female; Male; Myosin Light Chains; Phosphorylation; Rabbits; rho-Associated Kinases; Shock, Septic; Tumor Necrosis Factor-alpha; Vasoconstriction

2019
Abrupt Discontinuation Versus Down-Titration of Vasopressin in Patients Recovering from Septic Shock.
    Shock (Augusta, Ga.), 2021, 02-01, Volume: 55, Issue:2

    Topics: Aged; Arginine Vasopressin; Cohort Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Septic; Treatment Outcome; Withholding Treatment

2021
[Investigation of vasopressin response to increasing osmotic pressure in the late-phase of septic shock patients].
    Zhonghua wei zhong bing ji jiu yi xue, 2014, Volume: 26, Issue:1

    Topics: Aged; Aged, 80 and over; APACHE; Arginine Vasopressin; Female; Humans; Male; Middle Aged; Osmotic Pressure; Prospective Studies; Shock, Septic

2014
Early vasopressin reduces incidence of new onset arrhythmias.
    Journal of critical care, 2014, Volume: 29, Issue:4

    Topics: Aged; Arginine Vasopressin; Arrhythmias, Cardiac; Catecholamines; Critical Illness; Drug Administration Schedule; Female; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Shock, Septic; Vasopressins

2014
Beneficial and side effects of arginine vasopressin and terlipressin for septic shock.
    The Journal of surgical research, 2015, May-15, Volume: 195, Issue:2

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Calcium; Dose-Response Relationship, Drug; Female; Lypressin; Male; Norepinephrine; Rabbits; Rats; Rats, Sprague-Dawley; Sex Characteristics; Shock, Septic; Terlipressin

2015
The impact of endocrine supplementation on adverse events in septic shock.
    Journal of critical care, 2015, Volume: 30, Issue:6

    Topics: Adrenal Cortex Hormones; Aged; Arginine Vasopressin; Critical Care; Endocrine System; Female; Hemodynamics; Hospital Mortality; Humans; Hydrocortisone; Incidence; Intensive Care Units; Male; Middle Aged; Norepinephrine; Retrospective Studies; Shock, Septic; Vasopressins

2015
A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
    Critical care medicine, 2016, Volume: 44, Issue:1

    Topics: Animals; Arginine Vasopressin; Female; Norepinephrine; Random Allocation; Receptors, Vasopressin; Sheep; Sheep Diseases; Shock, Septic; Vasoconstrictor Agents; Vasopressins

2016
Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
    Critical care (London, England), 2015, Nov-27, Volume: 19

    Topics: Arginine Vasopressin; Ascorbic Acid; Hemodynamics; Humans; Norepinephrine; Sepsis; Shock, Septic; Vasoconstrictor Agents; Vasopressins

2015
Selepressin in Septic Shock: A Step Toward Decatecholaminization?
    Critical care medicine, 2016, Volume: 44, Issue:1

    Topics: Animals; Arginine Vasopressin; Female; Norepinephrine; Receptors, Vasopressin; Sheep Diseases; Shock, Septic; Vasoconstrictor Agents; Vasopressins

2016
Vasopressin, Norepinephrine, and Vasodilatory Shock after Cardiac Surgery: Another "VASST" Difference?
    Anesthesiology, 2017, Volume: 126, Issue:1

    Topics: Arginine Vasopressin; Humans; Norepinephrine; Shock; Shock, Septic; Vasoconstrictor Agents; Vasodilation; Vasopressins

2017
Vasopressin in critical illness: sometimes even old players leave a lot to discover. Preface.
    Best practice & research. Clinical anaesthesiology, 2008, Volume: 22, Issue:2

    Topics: Arginine Vasopressin; Critical Illness; Humans; Receptors, Vasopressin; Shock, Septic; Vasoconstrictor Agents; Vasopressins

2008
Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Journal of critical care, 2008, Volume: 23, Issue:4

    Topics: Academic Medical Centers; Aged; APACHE; Arginine Vasopressin; Drug Therapy, Combination; Female; Fludrocortisone; Glucocorticoids; Humans; Hydrocortisone; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Shock, Septic; Vasoconstrictor Agents

2008
Thermoregulation and vasopressin secretion during polymicrobial sepsis.
    Neuroimmunomodulation, 2009, Volume: 16, Issue:1

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Body Temperature Regulation; Disease Models, Animal; Disease Progression; Hypotension; Hypothalamus; Laparotomy; Male; Mortality; Nitric Oxide; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Sepsis; Shock, Septic; Supraoptic Nucleus; Up-Regulation

2009
The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
    Critical care medicine, 2009, Volume: 37, Issue:2

    Topics: Adult; Aged; Arginine Vasopressin; Cohort Studies; Female; Glycopeptides; Humans; Infections; Intensive Care Units; Male; Middle Aged; Sepsis; Severity of Illness Index; Shock, Septic

2009
Catecholamines, vasopressin and markers of acute liver injury in septic shock.
    Shock (Augusta, Ga.), 2009, Volume: 31, Issue:2

    Topics: Animals; Arginine Vasopressin; Biomarkers; Catecholamines; Humans; Liver; Liver Failure, Acute; Models, Biological; Perfusion; Resuscitation; Shock, Septic

2009
[Advanced vasodilatory shock. One-year survival after arginine vasopressin therapy].
    Der Anaesthesist, 2009, Volume: 58, Issue:2

    Topics: Aged; Arginine Vasopressin; Cause of Death; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Shock, Cardiogenic; Shock, Septic; Survival Analysis; Systemic Inflammatory Response Syndrome; Vasodilation

2009
Vasopressin and its copilot copeptin in sepsis and septic shock.
    Critical care medicine, 2009, Volume: 37, Issue:2

    Topics: Arginine Vasopressin; Clinical Trials as Topic; Glycopeptides; Humans; Sepsis; Shock, Septic; Vasopressins

2009
Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
    Intensive care medicine, 2009, Volume: 35, Issue:7

    Topics: Animals; Arginine Vasopressin; Drug Therapy, Combination; Female; Hemodynamics; Lypressin; Random Allocation; Sheep; Shock, Septic; Terlipressin; Vasoconstrictor Agents

2009
Comment: Terlipressin for children with extremely low cardiac output after open heart surgery.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:7

    Topics: Arginine Vasopressin; Cardiac Output, Low; Child; Hemodynamics; Humans; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents

2009
Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial.
    Critical care (London, England), 2009, Volume: 13, Issue:4

    Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Feces; Heart; Kidney; Liver; Norepinephrine; Peritonitis; Random Allocation; Shock, Septic; Swine

2009
Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
    Critical care (London, England), 2009, Volume: 13, Issue:4

    Topics: Animals; Arginine Vasopressin; Drug-Related Side Effects and Adverse Reactions; Norepinephrine; Shock, Septic; Sus scrofa; Vasoconstrictor Agents

2009
Vasopressin synthesis by the magnocellular neurons is different in the supraoptic nucleus and in the paraventricular nucleus in human and experimental septic shock.
    Brain pathology (Zurich, Switzerland), 2010, Volume: 20, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine Vasopressin; Disease Models, Animal; Female; Humans; Male; Middle Aged; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Shock, Septic; Supraoptic Nucleus

2010
Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock.
    Critical care medicine, 2010, Volume: 38, Issue:10

    Topics: Adrenocorticotropic Hormone; Aged; Arginine Vasopressin; Blood Pressure; Calcitonin; Female; Humans; Hydrocortisone; Interleukin-10; Interleukin-6; Male; Middle Aged; Prospective Studies; Protein Precursors; Severity of Illness Index; Shock, Septic; Sodium; Water-Electrolyte Balance

2010
Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock.
    Critical care medicine, 2010, Volume: 38, Issue:10

    Topics: Animals; Arginine Vasopressin; Blood Gas Analysis; Blood Pressure; Drug Therapy, Combination; Hydrazones; Lung; Myocardial Contraction; Norepinephrine; Pulmonary Wedge Pressure; Pyridazines; Sheep; Shock, Septic; Simendan; Vascular Resistance; Vasoconstrictor Agents; Water-Electrolyte Balance

2010
Disorder of osmoregulation as a new pathogenetic mechanism of septic shock?
    Critical care medicine, 2010, Volume: 38, Issue:10

    Topics: Arginine Vasopressin; Humans; Shock, Septic; Water-Electrolyte Balance

2010
Vasopressin, levosimendan, and cardiovascular function in septic shock.
    Critical care medicine, 2010, Volume: 38, Issue:10

    Topics: Animals; Arginine Vasopressin; Cardiovascular System; Drug Therapy, Combination; Hydrazones; Norepinephrine; Pyridazines; Sheep; Shock, Septic; Simendan; Vasoconstrictor Agents

2010
Role of selective V1a receptor agonism in ovine septic shock.
    Critical care medicine, 2011, Volume: 39, Issue:1

    Topics: Animals; Arginine Vasopressin; Blood Gas Analysis; Disease Models, Animal; Female; Hemodynamics; Immunohistochemistry; Kaplan-Meier Estimate; Norepinephrine; Oxygen Consumption; Pulmonary Gas Exchange; Random Allocation; Receptors, Vasopressin; Reference Values; Sheep; Sheep, Domestic; Shock, Septic; Survival Rate; Vasotocin

2011
Mirror, mirror on the wall: Which is the best vasopressin receptor of them all?
    Critical care medicine, 2011, Volume: 39, Issue:1

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Blood Pressure Determination; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hemodynamics; Humans; Norepinephrine; Random Allocation; Receptors, Vasopressin; Reference Values; Sheep; Sheep, Domestic; Shock, Septic; Survival Rate; Vasotocin

2011
Vasopressin analogues and V1a receptor agonists in septic shock.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2011, Volume: 60, Issue:5

    Topics: Arginine Vasopressin; Catecholamines; Clinical Trials as Topic; Humans; Lypressin; Microcirculation; Perfusion; Receptors, Vasopressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents

2011
Influences of hydrocortisone therapy on arginine vasopressin plasma levels in septic shock.
    Wiener klinische Wochenschrift, 2011, Volume: 123, Issue:7-8

    Topics: Aged; Arginine Vasopressin; Humans; Hydrocortisone; Middle Aged; Shock, Septic

2011
Combined arginine vasopressin and levosimendan: a promising therapy for septic shock.
    Critical care medicine, 2011, Volume: 39, Issue:4

    Topics: Animals; Arginine Vasopressin; Drug Therapy, Combination; Humans; Hydrazones; Pyridazines; Sheep; Shock, Septic; Simendan; Vasodilator Agents

2011
Arginine-vasopressin and corticosteroids in septic shock: engaged but not yet married!
    Intensive care medicine, 2011, Volume: 37, Issue:9

    Topics: Anti-Inflammatory Agents; Arginine Vasopressin; Female; Hemostatics; Humans; Hydrocortisone; Male; Shock, Septic

2011
Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality.
    Intensive care medicine, 2011, Volume: 37, Issue:9

    Topics: Aged; Anti-Inflammatory Agents; Arginine Vasopressin; Austria; Cohort Studies; Drug Therapy, Combination; Female; Hemostatics; Humans; Hydrocortisone; Intensive Care Units; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Retrospective Studies; Shock, Septic

2011
Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.
    Inflammation, 2012, Volume: 35, Issue:3

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Drug Therapy, Combination; Female; Hemodynamics; HMG-Box Domains; Hydrazones; Inflammation; Interleukin-6; Lactic Acid; Lung; Nitrates; Nitrites; Norepinephrine; Peritonitis; Pulmonary Artery; Pulmonary Gas Exchange; Pyridazines; Random Allocation; Respiratory Physiological Phenomena; Shock, Septic; Simendan; Swine

2012
Changes in CRH and ACTH synthesis during experimental and human septic shock.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Disease Models, Animal; Humans; Immunohistochemistry; In Situ Hybridization; Nitric Oxide Synthase Type II; Rats; Receptors, Vasopressin; RNA, Messenger; Shock, Septic

2011
Predictors of prolonged vasopressin infusion for the treatment of septic shock.
    Journal of critical care, 2012, Volume: 27, Issue:3

    Topics: Adult; Arginine Vasopressin; Cohort Studies; Female; Hemodynamics; Humans; Logistic Models; Male; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors; Shock, Septic; Survival Rate; Time Factors; United States; Vasoconstrictor Agents

2012
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor.
    Critical care medicine, 2012, Volume: 40, Issue:6

    Topics: Animals; Arginine Vasopressin; Blood Coagulation; Female; Prospective Studies; Random Allocation; Receptors, Vasopressin; Sheep; Shock, Septic; Vasopressins; von Willebrand Factor

2012
Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects.
    Journal of applied physiology (Bethesda, Md. : 1985), 2003, Volume: 95, Issue:2

    Topics: Animals; Arginine Vasopressin; Biological Availability; Biological Transport; Dogs; Hemodynamics; Injections, Intravenous; Intestinal Mucosa; Norepinephrine; Oxygen; Portal Vein; Regional Blood Flow; Renal Circulation; Resuscitation; Shock, Septic; Splanchnic Circulation; Stroke Volume; Vasoconstrictor Agents

2003
Treatment of endotoxic shock--the dilemma of vasopressor and vasodilator therapy.
    California medicine, 1962, Volume: 96

    Topics: Animals; Antitoxins; Arginine Vasopressin; Arterioles; Blood Pressure; Dogs; Hemodynamics; Shock; Shock, Septic; Toxins, Biological; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins

1962
INFLUENCE OF VASOPRESSORS ON SURVIVAL AFTER TRAUMATIC, INTESTINAL ISCHEMIA AND ENDOTOXIN SHOCK IN RATS.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1965, Volume: 119

    Topics: Angiotensins; Arginine Vasopressin; Endotoxins; Felypressin; Intestinal Diseases; Ischemia; Norepinephrine; Pharmacology; Rats; Research; Shock, Septic; Shock, Traumatic; Vasoconstrictor Agents; Vasopressins

1965
Role of nitric oxide in thermoregulation during septic shock: involvement of vasopressin.
    Pflugers Archiv : European journal of physiology, 2003, Volume: 447, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Body Temperature; Body Temperature Regulation; Enzyme Inhibitors; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Shock, Septic

2003
Arginine vasopressin compromises gut mucosal microcirculation in septic rats.
    Critical care medicine, 2004, Volume: 32, Issue:1

    Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Infusions, Intravenous; Intestinal Mucosa; Male; Microcirculation; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Regional Blood Flow; Risk Factors; Sensitivity and Specificity; Shock, Septic

2004
Are vasodilatory shock states due to sepsis and cardiovascular surgery like two peas in a pod?
    Critical care medicine, 2004, Volume: 32, Issue:6

    Topics: Arginine Vasopressin; Cardiac Surgical Procedures; Humans; Postoperative Complications; Shock; Shock, Septic

2004
Lessons learned from high-dosage vasopressin infusion in septic shock.
    Critical care medicine, 2004, Volume: 32, Issue:6

    Topics: Arginine Vasopressin; Hemodynamics; Humans; Shock, Septic

2004
Comment on "Role of vasopressin in the management of septic shock" by Mutlu and Factor.
    Intensive care medicine, 2004, Volume: 30, Issue:10

    Topics: Arginine Vasopressin; Blood Circulation; Blood Pressure; Humans; Lypressin; Pulmonary Circulation; Shock, Septic; Vasoconstrictor Agents; Vasopressins

2004
Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits.
    Critical care medicine, 2004, Volume: 32, Issue:9

    Topics: Analysis of Variance; Animals; Arginine Vasopressin; Blood Flow Velocity; Dose-Response Relationship, Drug; Hemodynamics; Kidney Cortex; Kidney Medulla; Laser-Doppler Flowmetry; Male; Microcirculation; Prospective Studies; Rabbits; Random Allocation; Regression Analysis; Renal Circulation; Shock, Septic; Vasoconstrictor Agents

2004
Is low-dose vasopressin the new reno-protective agent?
    Critical care medicine, 2004, Volume: 32, Issue:9

    Topics: Acute Kidney Injury; Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Renal Circulation; Shock, Septic; Vasoconstrictor Agents

2004
Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.
    Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:1

    Topics: Acute Kidney Injury; Angiotensin II; Animals; Arginine Vasopressin; Enzyme Inhibitors; Glomerular Filtration Rate; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Renal Circulation; Shock, Septic; Urine; Vasoconstrictor Agents

2005
Dear vasopressin, where is your place in septic shock?
    Critical care (London, England), 2005, Volume: 9, Issue:2

    Topics: Arginine Vasopressin; Catecholamines; Critical Care; Drug Therapy, Combination; Hemodynamics; Hormone Replacement Therapy; Humans; Norepinephrine; Shock, Septic; Vasoconstrictor Agents

2005
Vasopressin release during endotoxaemic shock in mice lacking inducible nitric oxide synthase.
    Pflugers Archiv : European journal of physiology, 2005, Volume: 450, Issue:6

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Female; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; Shock, Septic

2005
[Pathogenesis and therapeutic strategy].
    Medizinische Monatsschrift fur Pharmazeuten, 2005, Volume: 28, Issue:7

    Topics: Acute Kidney Injury; Animals; Arginine Vasopressin; Glucocorticoids; Humans; Hyperglycemia; Nitric Oxide; Nitric Oxide Synthase; Rats; Renal Agents; Renal Dialysis; Sepsis; Shock, Septic

2005
Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ.
    Intensive care medicine, 2006, Volume: 32, Issue:1

    Topics: Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Jejunum; Microcirculation; Oxygen; Shock, Septic; Splanchnic Circulation; Swine; Vasoconstrictor Agents

2006
Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model.
    Intensive care medicine, 2006, Volume: 32, Issue:1

    Topics: Analysis of Variance; Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Intestinal Mucosa; Jejunum; Microcirculation; Oxygen; Partial Pressure; Random Allocation; Shock, Septic; Spectrophotometry; Splanchnic Circulation; Swine; Vasoconstrictor Agents

2006
Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury.
    Critical care (London, England), 2006, Volume: 10, Issue:3

    Topics: Acute Kidney Injury; Arginine Vasopressin; Blood Pressure; Catecholamines; Female; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Male; Prospective Studies; Shock, Septic

2006
Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock.
    Anaesthesia and intensive care, 2006, Volume: 34, Issue:4

    Topics: Arginine Vasopressin; Chronic Disease; Critical Care; Glycopeptides; Hemodynamics; Humans; Hypertension; Intestinal Perforation; Male; Middle Aged; Peritonitis; Shock, Septic; Streptococcal Infections; Streptococcus milleri Group

2006
A century of arginine vasopressin research leading to new therapeutic strategies.
    Anesthesiology, 2006, Volume: 105, Issue:3

    Topics: Arginine Vasopressin; Clinical Trials as Topic; Heart Arrest; Humans; Shock, Hemorrhagic; Shock, Septic

2006
Role of heme-oxygenase pathway on vasopressin deficiency during endotoxemic shock-like conditions.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:5

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Deuteroporphyrins; Diuresis; Enzyme Inhibitors; Heart Rate; Heme Oxygenase (Decyclizing); Hypotension; Lipopolysaccharides; Male; Rats; Rats, Wistar; Shock, Septic; Vasopressins

2006
Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock.
    Shock (Augusta, Ga.), 2007, Volume: 28, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine Vasopressin; Disease Models, Animal; Female; Glycopeptides; Humans; Male; Middle Aged; Papio ursinus; Protein Precursors; Retrospective Studies; Shock, Hemorrhagic; Shock, Septic

2007
Massive melena due to arginine-vasopressin for septic shock in two pediatric patients.
    Paediatric anaesthesia, 2008, Volume: 18, Issue:1

    Topics: Adolescent; Arginine Vasopressin; Child, Preschool; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Melena; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Shock, Septic; Vasoconstrictor Agents

2008
Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.
    Intensive care medicine, 2008, Volume: 34, Issue:7

    Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Hemodynamics; Hypotension; Intestines; Liver; Microcirculation; Rabbits; Shock, Septic; Splanchnic Circulation; Vasoconstrictor Agents

2008
Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
    Pharmacotherapy, 2008, Volume: 28, Issue:5

    Topics: Aged; Arginine Vasopressin; Body Mass Index; Creatinine; Female; Hemodynamics; Humans; Male; Middle Aged; Shock, Septic; Vasoconstrictor Agents

2008
Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat.
    Critical care medicine, 1995, Volume: 23, Issue:11

    Topics: Aldosterone; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Diuresis; Hematocrit; Immune Sera; Lipopolysaccharides; Male; Natriuresis; Prospective Studies; Rats; Rats, Wistar; Shock, Septic

1995
In vitro femoral arterial responses to vasoconstrictor and vasodilator agents in endotoxin shock.
    Life sciences, 1994, Volume: 54, Issue:1

    Topics: Acetylcholine; Animals; Arginine; Arginine Vasopressin; Bradykinin; Femoral Artery; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Shock, Septic; Vasoconstrictor Agents; Vasodilator Agents

1994
Hemodynamic and metabolic effects of vasopressin blockade in endotoxin shock.
    Surgery, 1997, Volume: 121, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Endotoxins; Hemodynamics; Hormone Antagonists; Ketone Bodies; Male; Mononuclear Phagocyte System; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Shock, Septic; Vasopressins

1997
Elevation of plasma endothelin concentrations during endotoxin shock in dogs.
    European journal of pharmacology, 1991, Dec-03, Volume: 205, Issue:3

    Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Arginine Vasopressin; Cattle; Cells, Cultured; Dogs; Endothelins; Endothelium, Vascular; Female; Hemodynamics; Hydrocortisone; Male; Renin; Shock, Septic

1991
Microvascular vasopressin effects during endotoxin shock in the rat.
    Circulatory shock, 1990, Volume: 30, Issue:2

    Topics: Animals; Arginine Vasopressin; Blood Flow Velocity; Blood Pressure; Endotoxins; Escherichia coli; Male; Microcirculation; Rats; Rats, Inbred Strains; Shock, Septic; Vasoconstriction

1990
Discovery and therapeutic utility of vasopressin antagonists in rats.
    Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 7

    Topics: Animals; Arginine Vasopressin; Dehydration; Diuresis; Dose-Response Relationship, Drug; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Rats; Shock, Septic; Vasopressins

1986
The role of endorphins and vasopressin in canine endotoxin shock.
    The Journal of surgical research, 1986, Volume: 41, Issue:6

    Topics: Animals; Arginine Vasopressin; beta-Endorphin; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Dogs; Endorphins; Endotoxins; Escherichia coli; Female; Heart Rate; Hydrocortisone; Kinetics; Male; Naloxone; Shock, Septic

1986
Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia.
    The American journal of physiology, 1985, Volume: 249, Issue:6 Pt 2

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Endotoxins; Epinephrine; Male; Norepinephrine; Pentobarbital; Prazosin; Rats; Rats, Inbred Strains; Renin; Shock, Septic; Sympathetic Nervous System; Vasopressins

1985